Back to top
more

LeMaitre Vascular (LMAT)

(Real Time Quote from BATS)

$102.40 USD

102.40
141,424

+3.77 (3.82%)

Updated Nov 6, 2024 03:14 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (89 out of 251)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

LeMaitre Vascular (LMAT) Surpasses Q3 Earnings and Revenue Estimates

by Zacks Equity Research

LeMaitre (LMAT) delivered earnings and revenue surprises of 11.36% and 2.17%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

BAX or LMAT: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

BAX vs. LMAT: Which Stock Is the Better Value Option?

BAX vs. LMAT: Which Stock Is the Better Value Option?

by Zacks Equity Research

BAX vs. LMAT: Which Stock Is the Better Value Option?

All You Need to Know About LeMaitre (LMAT) Rating Upgrade to Strong Buy

by Zacks Equity Research

LeMaitre (LMAT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Molina Healthcare Stock Rises 15.4% in 3 Months: Should You Buy?

by Zacks Equity Research

MOH stock is expected to benefit from contract wins, rising premiums and expansion initiatives.

Smart Investors Are Holding Acadia Healthcare Stock Now: Here's Why

by Zacks Equity Research

ACHC is expected to benefit from improved volumes, patient day growth and expansion initiatives.

Here's Why Universal Health Shares are Attracting Investors Now

by Zacks Equity Research

UHS remains well-poised for growth on improved patient days at its behavioral healthcare facilities, acquisitions and solid cash flows.

Select Medical Agrees to Acquire Valir Rehabilitation Hospital

by Zacks Equity Research

SEM enters a definitive agreement to acquire Valir Rehabilitation Hospital and expand its inpatient rehabilitation footprint in Oklahoma City.

Centene Stock Rises 29% in a Year: Evaluating the Road Ahead

by Zacks Equity Research

CNC gains from improved premiums and service revenues, acquisitions and adequate operating cash flows.

Acadia Healthcare Expands Behavioral Health Services in Iowa

by Zacks Equity Research

ACHC breaks ground on a new behavioral health hospital in Council Bluffs, addressing regional care shortages through a joint venture with Methodist Health System.

Ensign Group (ENSG) Up 50% in Past Year: More Growth on the Horizon?

by Zacks Equity Research

Ensign Group (ENSG) remains well-poised for growth on the back of improved skilled services revenues, higher rental revenues and adequate operating cash flows.

Why You Should Add HCA Healthcare (HCA) to Your Portfolio Now

by Zacks Equity Research

HCA Healthcare (HCA) remains well-poised for growth on growing emergency room visits, buyouts and solid cash flows.

LeMaitre (LMAT) Upgraded to Strong Buy: Here's Why

by Zacks Equity Research

LeMaitre (LMAT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Best Momentum Stock to Buy for August 6th

by Zacks Equity Research

HWKN, PPC and LMAT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 6, 2024.

LeMaitre Vascular (LMAT) Surpasses Q2 Earnings and Revenue Estimates

by Zacks Equity Research

LeMaitre (LMAT) delivered earnings and revenue surprises of 10.64% and 1.25%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

HLN vs. LMAT: Which Stock Is the Better Value Option?

by Zacks Equity Research

HLN vs. LMAT: Which Stock Is the Better Value Option?

Merit Medical (MMSI) Hits 52-Week High: What's Aiding It?

by Zacks Equity Research

Investors are optimistic about Merit Medical's (MMSI) strong product portfolio.

Glaukos (GKOS) Reaches 52-Week High: What's Driving the Stock?

by Zacks Equity Research

Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.

Intuitive Surgical (ISRG) Hits 52-Week High: What's Aiding It?

by Zacks Equity Research

Investors are optimistic about Intuitive Surgical's (ISRG) strength in robotics.

Encompass Health (EHC) Expands in Louisville With New Rehab Unit

by Zacks Equity Research

Encompass Health (EHC) and Baptist Health inaugurate a 40-bed inpatient rehabilitation hospital in Louisville, enhancing regional care and expanding EHC's network to 163 facilities.

GE HealthCare's (GEHC) New Tie-Up to Boost CVD Workflow

by Zacks Equity Research

GE HealthCare's (GEHC) latest collaboration is likely to enable clinicians to perform complex cardiology interventions with a high level of precision and improved image quality.

Encompass Health (EHC) Gains 30% in a Year: More Room to Run?

by Zacks Equity Research

Encompass Health (EHC) is well-poised for growth on the back of sustained top-line growth, an aging U.S. population, frequent expansion initiatives and strong cash reserves.

LeMaitre (LMAT) Upgraded to Strong Buy: Here's What You Should Know

by Zacks Equity Research

LeMaitre (LMAT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

New Strong Buy Stocks for June 21st

by Zacks Equity Research

ASYS, LAUR, ESLT, LNTH and LMAT have been added to the Zacks Rank #1 (Strong Buy) List on June 21, 2024.

Humana's (HUM) CenterWell Sets Foot in Asheville With New Centers

by Zacks Equity Research

Humana's (HUM) CenterWell Senior Primary Care announces the opening of two centers in Asheville, thus enhancing access to high-quality healthcare services and driving revenues of the CenterWell unit.